File:PMC4172812 13023 2014 143 Fig3 HTML.png

License

Attribution 4.0 International (CC BY 4.0)

&

CC0 1.0 Universal (CC0 1.0) Public Domain Dedication

Summary

Author:Sechi A, Dardis A, Zampieri S, Rabacchi C, Zanoni P, Calandra S, De Maglio G, Pizzolitto S, Maruotti V, Di Muzio A, Platt F, Bembi B,Regional Coordinator Centre for Rare Diseases, University Hospital Santa Maria della Misericordia, Department of Biomedical; Metabolic and Neural Sciences, University of Modena and Reggio Emilia,Department of Pathology, University-Hospital Santa Maria della Misericordia,Centre for Neuromuscular Diseases, University G. d’Annunzio,Department of Pharmacology, University of Oxford Source:https://openi.nlm.nih.gov/detailedresult?img=PMC4172812_13023_2014_143_Fig3_HTML&query=Tangier%20disease&it=xg&req=4&npos=1 Description:Fig3: Improvement of dorsal skin lesions after miglustat treatment. Images showing the improvement on miglustat treatment of the dorsal skin lesions resembling prurigo nodularis of the patient with Tangier Disease described in this study. Pictures taken A after 7 months of miglustat discontinuation; B after 6 months of miglustat treatment.